There are two variables that can see the acceleration of doses from Q3 to Q2, which we're working very hard on. The first is that we are working with approved suppliers to see if they would be willing to move doses from Q3 to Q2. We've had some success on that already, which I have announced previously, but we're still working to make sure that approved suppliers...and inquire with them to see if their doses can be moved earlier to Q2. That would be useful in accelerating our timelines.
The second variable is the speed at which additional approvals occur at the separate regulatory body of Health Canada. As we see additional vaccines come online, we will hopefully see accelerated deliveries of those vaccines and our numbers, previously provided in chart form and repeated here a number of times, also accelerating.
As you can see, this is an environment with many moving parts, where suppliers are ramping up production at the same time that regulatory bodies are approving new vaccines. It's very important for us to be aware that the targets we are setting are realistic. They can change, and as soon as we have information relating to additional deliveries to be expected in Q2 we will share that with the Canadian public. It's my commitment. It's our government's commitment.